Table 4.
Moderate target met |
Vigorous target met |
||||
---|---|---|---|---|---|
Odds | Minimum | More Extensive | Minimum | More extensive | |
NASHa | Unadjusted | 1.01 (0.62, 1.66) | 1.1 (0.56, 2.2) | 0.62 (0.42, 0.90) | 0.57 (0.36, 0.90) |
Adjusted | 1.24 (0.73, 2.1) | 1.46 (0.68, 3.1) | 0.65 (0.43, 0.98) | 0.56 (0.34, 0.90) | |
Advanced fibrosisb | Unadjusted | 1.1 (0.65, 1.8) | 1.1 (0.55, 2.0) | 0.53 (0.34, 0.82) | 0.41 (0.23, 0.72) |
Adjusted | 1.2 (0.69, 2.1) | 1.1 (0.53, 2.3) | 0.75 (0.46, 1.2) | 0.53 (0.29, 0.97) |
BMI, body mass index; NASH, nonalcoholic steatohepatitis.
Odds ratio (95% confidence interval) derived from multinomial logistic regression.
The adjusted odds ratios were adjusted for age, gender, income, BMI, and glucose.
Statistically significant odds ratios and confidence intervals are in bold font for emphasis.
Definite steatohepatitis vs. not steatohepatitis.
Advanced fibrosis vs. no fibrosis